Glycoside Steroids TRIZ Cases
- OCT4 Interaction Inhibitors for c-MYC-Driven Cancer Resistance
Compounds that block OCT4 binding to MAPKAPK2 or DNA-PKcs suppress c-MYC activation and help restore therapy response in cancer.
- Mogroside V Biocatalysis for High-Purity Siamenoside I Sweetener
Beta-galactosidase converts mogroside V into high-purity Siamenoside I, improving monk fruit sweetness profile while reducing contaminants.
- Polypodoside Sweet Modifiers for Sugar-Like Taste and Onset
Polypodoside compounds pair with high-intensity sweeteners to create a more sugar-like taste with less aftertaste.